Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Reviews in the Neurosciences

Editor-in-Chief: Huston, Joseph P.

Editorial Board Member: Topic, Bianca / Adeli, Hojjat / Buzsaki, Gyorgy / Crawley, Jacqueline / Crow, Tim / Eichenbaum, Howard / Gold, Paul / Holsboer, Florian / Korth, Carsten / Lubec, Gert / McEwen, Bruce / Pan, Weihong / Pletnikov, Mikhail / Robbins, Trevor / Schnitzler, Alfons / Stevens, Charles / Steward, Oswald / Trojanowski, John

8 Issues per year


IMPACT FACTOR 2016: 2.546
5-year IMPACT FACTOR: 3.191

CiteScore 2016: 3.30

SCImago Journal Rank (SJR) 2016: 1.249
Source Normalized Impact per Paper (SNIP) 2016: 0.983

Online
ISSN
2191-0200
See all formats and pricing
More options …
Volume 22, Issue 1 (Feb 2011)

Issues

Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development

Edward D. Levin
  • Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Box #104790, Durham, NC 27710, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-02-10 | DOI: https://doi.org/10.1515/rns.2011.009

Abstract

Zebrafish can provide a valuable animal model to screen potential cognitive enhancing and anxiolytic drugs. They are economical and can provide a relatively quick indication of possible functional efficacy. In as much as they have a complex nervous system and elaborate behavioral repertoire, zebrafish can provide a good intermediate model between in vitro receptor and cell-based assays and classic mammalian models for drug screening. In addition, the variety of molecular tools available in zebrafish makes them outstanding models for helping to determine the neuromolecular mechanisms for psychoactive drugs. However, to use zebrafish as a translational model we must have validated, sensitive and efficient behavioral tests. In a series of studies, our lab has developed tests of cognitive function and stress response, which are sensitive to drug effects in a similar manner as rodent models and humans for cognitive enhancement and alleviating stress response. In particular, the three-chamber task for learning and memory was shown to be sensitive to the cognitive enhancing effects of nicotine and has been useful in helping to determine neural mechanisms crucial for nicotinic-induced cognitive enhancement. The novel tank diving test was shown to be a valid and efficient test of stress response. It is sensitive to the reduction in stress-related behaviors due to the amxiolytic drugs diazepam and buspirone but not chlordiazepoxide. Nicotine also causes stress alleviating effects which can be interpreted as anxiolytic effects. Zebrafish models of behavioral pharmacology can be useful to efficiently screen test compounds for drug development and can be useful in helping to determine the mechanisms crucial for new therapeutic treatments of neurobehavioral impairments.

Keywords: anxiety; buspirone; diazepam; learning; memory; nicotine; zebrafish

About the article

Published Online: 2011-02-10

Published in Print: 2011-02-01


Citation Information: Reviews in the Neurosciences, ISSN (Online) 2191-0200, ISSN (Print) 0334-1763, DOI: https://doi.org/10.1515/rns.2011.009.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Fiona A. Desland, Aqeela Afzal, Zuha Warraich, and J Mocco
Journal of Central Nervous System Disease, 2014, Volume 6, Page JCNSD.S13194
[3]
Derek F. Burton, Chengjin Zhang, Oswald Boa-Amponsem, Shanta Mackinnon, and Gregory J. Cole
Neurotoxicology and Teratology, 2017, Volume 61, Page 66
[4]
Darya A. Meshalkina, Marina N. Kizlyk, Elana V. Kysil, Adam D. Collier, David J. Echevarria, Murilo S. Abreu, Leonardo J.G. Barcellos, Cai Song, and Allan V. Kalueff
Behavioural Processes, 2017, Volume 141, Page 229
[5]
Yiming Bai, Harrison Liu, Bo Huang, Mahendra Wagle, and Su Guo
BMC Neuroscience, 2016, Volume 17, Number 1
[6]
Laura J. Macaulay, Melissa Chernick, Albert Chen, David E. Hinton, Jordan M. Bailey, Seth W. Kullman, Edward D. Levin, and Heather M. Stapleton
Environmental Toxicology and Chemistry, 2017, Volume 36, Number 1, Page 36
[7]
Niveen Fulcher, Steven Tran, Soaleha Shams, Diptendu Chatterjee, and Robert Gerlai
Zebrafish, 2017, Volume 14, Number 1, Page 23
[8]
Jordan Bailey, Anthony Oliveri, and Edward D. Levin
Birth Defects Research Part C: Embryo Today: Reviews, 2013, Volume 99, Number 1, Page 14
[9]
Ana Cristina V.V. Giacomini, Murilo S. Abreu, Luidia V. Giacomini, Anna M. Siebel, Fernanda F. Zimerman, Cassiano L. Rambo, Ricieri Mocelin, Carla D. Bonan, Angelo L. Piato, and Leonardo J.G. Barcellos
Behavioural Brain Research, 2016, Volume 296, Page 301
[10]
David J. Jouandot, David J. Echevarria, and Elizabeth A. Lamb
Behaviour, 2012, Volume 149, Number 10-12, Page 1081
[11]
Simone Dereje, Susanna Sawyer, Sarah E. Oxendine, Linran Zhou, Zachary D. Kezios, Ryan Y. Wong, John Godwin, and Florence Perrin
Behaviour, 2012, Volume 149, Number 10-12, Page 1205
[12]
M.M. Bernardi, S.G. Dias, and V.E. Barbosa
Environmental Toxicology and Pharmacology, 2013, Volume 36, Number 3, Page 1276
[13]
Laura J. Macaulay, Jordan M. Bailey, Edward D. Levin, and Heather M. Stapleton
Neurotoxicology and Teratology, 2015, Volume 52, Page 119
[14]
Daniela Braida, Luisa Ponzoni, Roberta Martucci, Fabio Sparatore, Cecilia Gotti, and Mariaelvina Sala
Psychopharmacology, 2014, Volume 231, Number 9, Page 1975
[15]
Adam Michael Stewart, Leah Grossman, Adam D. Collier, David J. Echevarria, and Allan V. Kalueff
Pharmacology Biochemistry and Behavior, 2015, Volume 139, Page 112
[16]
J.M. Bailey, A.N. Oliveri, C. Zhang, J.M. Frazier, S. Mackinnon, G.J. Cole, and E.D. Levin
Neurotoxicology and Teratology, 2015, Volume 48, Page 1
[17]
Daniela Braida, Luisa Ponzoni, Roberta Martucci, and Mariaelvina Sala
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2014, Volume 55, Page 80
[18]
Caio Maximino, Monica Gomes Lima, Karen Renata Matos Oliveira, Evander de Jesus Oliveira Batista, and Anderson Manoel Herculano
Journal of Chemical Neuroanatomy, 2013, Volume 48-49, Page 1
[19]
Lee David Ellis and Kelly Howard Soanes
Behavioural Brain Research, 2012, Volume 233, Number 2, Page 450
[20]
Roger L. Papke, Fumihito Ono, Clare Stokes, Jason M. Urban, and R. Thomas Boyd
Biochemical Pharmacology, 2012, Volume 84, Number 3, Page 352
[21]
Matthew O. Parker, Jessica Gaviria, Alastair Haigh, Mollie E. Millington, Verity J. Brown, Fraser J. Combe, and Caroline H. Brennan
Behavioural Brain Research, 2012, Volume 232, Number 1, Page 264
[22]
Ruxandra M. Luca and Robert Gerlai
Behavioural Brain Research, 2012, Volume 229, Number 1, Page 194
[23]
Edward D. Levin, Damiyon Sledge, Stephanie Roach, Ann Petro, Susan Donerly, and Elwood Linney
Neurotoxicology and Teratology, 2011, Volume 33, Number 6, Page 668

Comments (0)

Please log in or register to comment.
Log in